Quantitation and Detection of BRAF V600E Mutation in Papillary Thyroid Carcinoma

被引：0
|
作者：
Sirohi, D. [1 ]
Wang, Y. [1 ]
Lindner, J. R. [1 ]
Vadlamudi, K. [1 ]
Furmaga, W. B. [1 ]
Fan, H. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
647
引用
收藏
页码：159A / 160A
页数：2
相关论文
共 50 条
  • [1] Quantitation and Detection of BRAF V600E Mutation in Papillary Thyroid Carcinoma
    Sirohi, D.
    Wang, Y.
    Lindner, J. R.
    Vadlamudi, K.
    Furmaga, W. B.
    Fan, H.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 159A - 160A
  • [2] Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma
    Zagzag, Jonathan
    Pollack, Aron
    Dultz, Linda
    Dhar, Shumon
    Ogilvie, Jennifer B.
    Heller, Keith S.
    Deng, Fang-Ming
    Patel, Kepal N.
    [J]. SURGERY, 2013, 154 (06) : 1199 - 1204
  • [3] Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
    He, Guoping
    Zhao, Baojian
    Zhang, Xu
    Gong, Rixiang
    [J]. ONCOLOGY LETTERS, 2014, 7 (02) : 439 - 443
  • [4] BRAF V600E Mutation and Papillary Thyroid Cancer
    Ciarrocchi, Alessia
    Cavuto, Silvio
    Piana, Simonetta
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (05): : 534 - 534
  • [5] Investigation of BRAF V600E detection approaches in papillary thyroid carcinoma
    Chen, Dan
    Qi, Wenjing
    Zhang, Pengxin
    Zhang, Yunkun
    Liu, Ye
    Guan, Hongwei
    Wang, Lifen
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (02) : 303 - 307
  • [6] Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma
    Zhu, Xiaoli
    Luo, Yanli
    Bai, Qianming
    Lu, Yongming
    Lu, Yiqiong
    Wu, Lijing
    Zhou, Xiaoyan
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2016, 100 (01) : 236 - 241
  • [7] Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma DISCUSSION
    Yip, Linwah
    Zagzag, Jonathan
    Moo-Young, Tricia A.
    Nilubol, Naris
    Sippel, Rebecca S.
    Solorzano, Carmen C.
    Parangi, Sareh
    [J]. SURGERY, 2013, 154 (06) : 1204 - 1205
  • [8] Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population
    Brzezianska, Ewa
    Pastuszak-Lewandoska, Dorota
    Wojciechowska, Katarzyna
    Migdalska-Sek, Monika
    Cyniak-Magierska, Anna
    Nawrot, Ewa
    Lewinski, Andrzej
    [J]. NEUROENDOCRINOLOGY LETTERS, 2007, 28 (04) : 351 - 359
  • [9] Lack of MAPK activation in papillary thyroid carcinoma with BRAF V600E mutation
    Zuo, Hui
    Nakamura, Yasushi
    Yasuoka, Hironao
    Nakamura, Misa
    Mori, Ichiro
    Miyauchi, Akira
    Kakudo, Kennichi
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [10] BRAF(V600E) mutation and the biology of papillary thyroid cancer
    Frasca, F.
    Nucera, C.
    Pellegriti, G.
    Gangemi, P.
    Attard, M.
    Stella, M.
    Loda, M.
    Vella, V.
    Giordano, C.
    Trimarchi, F.
    Mazzon, E.
    Belfiore, A.
    Vigneri, R.
    [J]. ENDOCRINE-RELATED CANCER, 2008, 15 (01) : 191 - 205
12345